26.1 C
Sunday, April 21, 2024

Tag: ENYO Pharma

ENYO Pharma Announces a €39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With...

Business Wire India The Company will initiate a Phase 2 clinical study of Vonafexor in Alport Syndrome - called “ALPESTRIA-1” - in the first...

- A word from our sponsors -


Follow us

HomeTagsENYO Pharma